Pricing Log in Create free account

Maze Therapeutics, Inc. (MAZE) vs Trevi Therapeutics, Inc. (TRVI)

Maze Therapeutics, Inc. and Trevi Therapeutics, Inc. are both Biotechnology companies. Maze Therapeutics, Inc. and Trevi Therapeutics, Inc. are of similar size ($1.8B and $1.8B). Across the 10 metrics below, Trevi Therapeutics, Inc. leads on 7 and Maze Therapeutics, Inc. on 3.

Valuation

Metric MAZE TRVI Biotechnology median
P/E n/m n/m 8.58
P/S n/m n/m 10.29
P/B 4.17 6.28 2.29
Price to free cash flow n/m n/m 21.93
EV/EBITDA n/m n/m 0.67
EV/Sales n/m n/m 9.89
Earnings yield (7.87%) (2.64%) (31.56%)
Free cash flow yield (5.66%) (2.62%) (23.42%)

Profitability

Metric MAZE TRVI Biotechnology median
Gross margin — 0.00% 65.77%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (37.35%) (19.66%) (54.09%)
Return on assets (31.99%) (18.97%) (47.78%)
Return on invested capital (112.36%) (1,412.11%) 0.00%

Growth

Metric MAZE TRVI Biotechnology median
Revenue growth (TTM) — — 5.83%
EPS growth (last fiscal year) (344.00%) 31.91% 29.36%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric MAZE TRVI Biotechnology median
Debt to equity 0.09 0.00 0.00
Current ratio 18.31 37.28 4.80
Net debt to EBITDA 2.43 3.83 0.97

Dividend

Metric MAZE TRVI Biotechnology median
Dividend yield — — 0.44%
Payout ratio — — —

Size

Metric MAZE TRVI Biotechnology median
Market cap 1.81b 1.82b 153.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack